title: Reduce disease burden and improve lung function-roflumilast: approved for moderate to severe COPD: update for the clinical nurse specialist.
authors.affiliation: Miami Valley Hospital, 1 Wyoming Street, Dayton, OH, USA. pomalley@mvh.org
authors.forename: Patricia
authors.initials: P
authors.lastname: O'Malley
mesh_terms: D000631:Aminopyridines / Q000009:adverse effects / Q000627:therapeutic use*; D001549:Benzamides / Q000009:adverse effects / Q000627:therapeutic use*; D017281:Cost of Illness; D003521:Cyclopropanes / Q000009:adverse effects / Q000627:therapeutic use; D018450:Disease Progression; D017277:Drug Approval; D006801:Humans; D009720:Nurse Clinicians / Q000193:education*; D058988:Phosphodiesterase 4 Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy* / Q000503:physiopathology / Q000517:prevention & control; D012720:Severity of Illness Index
chemical_list: D000631:Aminopyridines; D001549:Benzamides; D003521:Cyclopropanes; D058988:Phosphodiesterase 4 Inhibitors; C424423:Roflumilast